Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05976165 · ClinicalTrials.gov registry record · NA
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
A NA study of Gastroesophageal Reflux and Heartburn, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05976165: Recruiting NA study of Gastroesophageal Reflux and Heartburn, sponsored by Mayo Clinic.
NCT05976165 is a NA study of Gastroesophageal Reflux and Heartburn that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05976165, a NA study of Gastroesophageal Reflux and Heartburn, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.
Primary Outcome
Number of subjects to have a positive breath testing for small intestinal bacterial overgrowth (SIBO) after clinical treatment of proton pump inhibitors (PPI ).
Conditions Studied
Interventions
- OTHER Breath Testing
Study Locations (1)
Florida
- Mayo Clinic Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-11-17 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT05976165 shows while recruiting
NCT05976165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Breath Testing is the first listed.
NCT05976165 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05976165 about?
NCT05976165 is a clinical study titled "A Study of Breath Testing for Small Intestinal Bacterial Overgrowth". Researchers hope to determine how often small intestinal bacterial overgrowth occurs after taking proton pump inhibitors.
What is the current status of trial NCT05976165?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-11-17. Estimated completion is 2027-01-31.
What conditions does trial NCT05976165 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux, Heartburn, Regurgitation.
What interventions are being tested in trial NCT05976165?
The interventions under investigation include: Breath Testing (OTHER).
Who is sponsoring clinical trial NCT05976165?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05976165 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05976165's enrollment target sits among peer trials
50 22nd of 33 higher than 12 of 33 other Gastroesophageal Reflux trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
External UES Band (Shaker Pressure Band) and GERD
RECRUITING · NA
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RECRUITING · NA
-
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
RECRUITING · NA
-
Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI